151 related articles for article (PubMed ID: 35946134)
21. Linc-ROR promotes mesenchymal stem cells chondrogenesis and cartilage formation via regulating SOX9 expression.
Feng L; Yang ZM; Li YC; Wang HX; Lo JHT; Zhang XT; Li G
Osteoarthritis Cartilage; 2021 Apr; 29(4):568-578. PubMed ID: 33485931
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
23. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
24. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.
Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J
Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071
[TBL] [Abstract][Full Text] [Related]
25. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
26. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.
Fu Z; Li G; Li Z; Wang Y; Zhao Y; Zheng S; Ye H; Luo Y; Zhao X; Wei L; Liu Y; Lin Q; Zhou Q; Chen R
Cell Death Discov; 2017; 3():17004. PubMed ID: 28580169
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of LINC-ROR in cancer cell lines and tissues.
Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P
Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857
[TBL] [Abstract][Full Text] [Related]
28. Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Arunkumar G; Deva Magendhra Rao AK; Manikandan M; Arun K; Vinothkumar V; Revathidevi S; Rajkumar KS; Rajaraman R; Munirajan AK
Tumour Biol; 2017 Apr; 39(4):1010428317698366. PubMed ID: 28443494
[TBL] [Abstract][Full Text] [Related]
29. The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4.
Li X; Chen W; Jia J; You Z; Hu C; Zhuang Y; Lin Z; Liu Y; Yang C; Xu R
Onco Targets Ther; 2020; 13():2573-2581. PubMed ID: 32273727
[TBL] [Abstract][Full Text] [Related]
30. Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu PF
Oncotarget; 2016 Sep; 7(37):59604-59617. PubMed ID: 27449099
[TBL] [Abstract][Full Text] [Related]
31. Arsenite Increases Linc-ROR in Human Bronchial Epithelial Cells that Can Be Inhibited by Antioxidant Factors.
Li X; Zuo C; Sun D; Zhao T; Zhang Z
Biol Trace Elem Res; 2020 Nov; 198(1):131-141. PubMed ID: 32030632
[TBL] [Abstract][Full Text] [Related]
32. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
33. Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR.
He X; Yu J; Xiong L; Liu Y; Fan L; Li Y; Chen B; Chen J; Xu X
Gene; 2019 Nov; 719():144044. PubMed ID: 31400406
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway.
Hou L; Tu J; Cheng F; Yang H; Yu F; Wang M; Liu J; Fan J; Zhou G
Cancer Cell Int; 2018; 18():142. PubMed ID: 30250400
[TBL] [Abstract][Full Text] [Related]
36. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling.
Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T
Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145.
Zhou P; Sun L; Liu D; Liu C; Sun L
Pathol Oncol Res; 2016 Oct; 22(4):733-40. PubMed ID: 27071407
[TBL] [Abstract][Full Text] [Related]
38. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
39. Linc-RoR promotes c-Myc expression through hnRNP I and AUF1.
Huang J; Zhang A; Ho TT; Zhang Z; Zhou N; Ding X; Zhang X; Xu M; Mo YY
Nucleic Acids Res; 2016 Apr; 44(7):3059-69. PubMed ID: 26656491
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
Chen Y; Shen Z; Zhi Y; Zhou H; Zhang K; Wang T; Feng B; Chen Y; Song H; Wang R; Chu X
Arch Biochem Biophys; 2018 May; 645():117-125. PubMed ID: 29559320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
